Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 1
1978 2
1979 1
1980 4
1981 3
1983 4
1984 5
1985 2
1986 3
1987 7
1988 5
1989 5
1990 7
1991 8
1992 8
1993 21
1994 9
1995 14
1996 24
1997 22
1998 11
1999 25
2000 21
2001 35
2002 35
2003 52
2004 44
2005 63
2006 79
2007 81
2008 80
2009 75
2010 74
2011 85
2012 95
2013 131
2014 109
2015 120
2016 126
2017 134
2018 140
2019 167
2020 203
2021 216
2022 220
2023 217
2024 106

Text availability

Article attribute

Article type

Publication date

Search Results

2,562 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for mean bu
Your search for Zean Bu retrieved no results
Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies.
Trinquart L, Bill-Axelson A, Rider JR. Trinquart L, et al. Eur Urol. 2019 Aug;76(2):137-139. doi: 10.1016/j.eururo.2019.04.002. Epub 2019 Apr 26. Eur Urol. 2019. PMID: 31031048
We describe an easily estimated complementary measure, the difference in restricted mean survival time (RMST), that requires fewer assumptions than the HR and is more readily interpretable. ...
We describe an easily estimated complementary measure, the difference in restricted mean survival time (RMST), that requires fewer as …
Infliximab therapy in Behçet's uveitis.
Alizadegan F, Yalcinbayir O, Ucan Gunduz G, Pehlivan Y. Alizadegan F, et al. J Fr Ophtalmol. 2022 Nov;45(9):1036-1041. doi: 10.1016/j.jfo.2022.04.009. Epub 2022 Sep 20. J Fr Ophtalmol. 2022. PMID: 36150991
RESULTS: Sixty-two eyes of 35 patients on IFX therapy were included in the study. The mean follow-up was 49.525.9months. The mean frequency of recurrences during the IMT was 1.470.78 (attacks/year), decreasing to 0.310.40 (attacks/year) with IFX (P<0.001). ...CON …
RESULTS: Sixty-two eyes of 35 patients on IFX therapy were included in the study. The mean follow-up was 49.525.9months. The mean …
Bleeding in primary shoulder arthroplasty.
Malcherczyk D, Abdelmoula A, Heyse TJ, Peterlein CD, Greene B, El-Zayat BF. Malcherczyk D, et al. Arch Orthop Trauma Surg. 2018 Mar;138(3):317-323. doi: 10.1007/s00402-017-2851-3. Epub 2017 Dec 6. Arch Orthop Trauma Surg. 2018. PMID: 29214382
The demographic data, co-morbidities, haemoglobin and hematocrit level, BT rate, amount of transfused BU etc. were collected. TBL was estimated. Linear regression, log-linear poisson regression and logistic regression were used to compare the outcomes TBL, amount of transf …
The demographic data, co-morbidities, haemoglobin and hematocrit level, BT rate, amount of transfused BU etc. were collected. TBL was …
The Impact of Diplopia on Reading.
Lijka B, Toor S, Arblaster G. Lijka B, et al. Br Ir Orthopt J. 2019 Jan 21;15(1):8-14. doi: 10.22599/bioj.122. Br Ir Orthopt J. 2019. PMID: 32999969 Free PMC article.
Three viewing conditions were created using Fresnel prisms on plano glasses: a control condition without diplopia (6 prism dioptres (delta) base up (BU) over each eye), small separation vertical diplopia (3delta BU right eye and 3delta base down (BD) left eye) and l …
Three viewing conditions were created using Fresnel prisms on plano glasses: a control condition without diplopia (6 prism dioptres (delta) …
Characterization of BRCA Deficiency in Ovarian Cancer.
Barbero G, Zuntini R, Magini P, Desiderio L, Bonaguro M, Perrone AM, Rubino D, Grippa M, De Leo A, Ceccarelli C, Godino L, Miccoli S, Ferrari S, Santini D, De Iaco P, Zamagni C, Innella G, Turchetti D. Barbero G, et al. Cancers (Basel). 2023 Feb 28;15(5):1530. doi: 10.3390/cancers15051530. Cancers (Basel). 2023. PMID: 36900320 Free PMC article.
BD tumors, compared to BU, showed a significantly higher rate of small genomic rearrangements. After a median follow-up of 60.3 months, the mean PFS was 54.9 27.2 months in BD patients and 34.6 26.7 months in BU patients (p = 0.055). ...
BD tumors, compared to BU, showed a significantly higher rate of small genomic rearrangements. After a median follow-up of 60.3 month …
Busulfan systemic exposure and its relationship with efficacy and safety in hematopoietic stem cell transplantation in children: a meta-analysis.
Feng X, Wu Y, Zhang J, Li J, Zhu G, Fan D, Yang C, Zhao L. Feng X, et al. BMC Pediatr. 2020 Apr 20;20(1):176. doi: 10.1186/s12887-020-02028-6. BMC Pediatr. 2020. PMID: 32312247 Free PMC article. Review.
RESULTS: Thirteen studies involving 548 pediatric patients (aged 0.3-18 years) were included. Pooled results showed that, compared with the mean Bu AUC (i.e., the average value of AUC measured multiple times for each patient) of > 900 muM min, the mean AUC …
RESULTS: Thirteen studies involving 548 pediatric patients (aged 0.3-18 years) were included. Pooled results showed that, compared with the …
Quantum entropy and central limit theorem.
Bu K, Gu W, Jaffe A. Bu K, et al. Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2304589120. doi: 10.1073/pnas.2304589120. Epub 2023 Jun 12. Proc Natl Acad Sci U S A. 2023. PMID: 37307444 Free PMC article.
We introduce a framework to study discrete-variable (DV) quantum systems based on qudits. It relies on notions of a mean state (MS), a minimal stabilizer-projection state (MSPS), and a new convolution. ...We establish a central limit theorem, based on iterating the convolu …
We introduce a framework to study discrete-variable (DV) quantum systems based on qudits. It relies on notions of a mean state (MS), …
Profile of cancer patients' seen at Korle Bu teaching hospital in Ghana (a cancer registry review).
Calys-Tagoe BN, Yarney J, Kenu E, Amanhyia NA, Enchill E, Obeng I. Calys-Tagoe BN, et al. BMC Res Notes. 2014 Aug 27;7:577. doi: 10.1186/1756-0500-7-577. BMC Res Notes. 2014. PMID: 25164384 Free PMC article. Review.
RESULTS: A total of 1136 patients with cancer were studied. Their ages ranged from 1 year to 92 years with a mean of 52.3 15.9 years and a median of 54 years. Patients were predominantly female (70.2%) and majority had attained secondary level of education or higher. ...CO …
RESULTS: A total of 1136 patients with cancer were studied. Their ages ranged from 1 year to 92 years with a mean of 52.3 15.9 years …
Clinical characteristics of COVID-19 patients admitted at the Korle-Bu Teaching Hospital, Accra, Ghana.
Adjei P, Afriyie-Mensah J, Ganu VJ, Puplampu P, Opoku-Asare B, Dzefi-Tettey K, Amissah-Arthur MB, Tachi K, Boima V, Dey D, Akamah J, Akpalu A, Akpalu J, Amoo P, Otchi E, Marfoh K, Agyei-Nkansah A. Adjei P, et al. Ghana Med J. 2020 Dec;54(4 Suppl):33-38. doi: 10.4314/gmj.v54i4s.6. Ghana Med J. 2020. PMID: 33976439 Free PMC article.
SETTING: The study was conducted at the COVID-19 Treatment Center of the Department of Medicine and Therapeutics of the Korle-Bu Teaching hospital in Accra, Ghana. PARTICIPANTS AND STUDY TOOLS: A total of fifty patients with laboratory (rRT-PCR) confirmed COVID-19 infectio …
SETTING: The study was conducted at the COVID-19 Treatment Center of the Department of Medicine and Therapeutics of the Korle-Bu Teac …
Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.
Wagh H, Arif A, Reddy AJ, Tabaie E, Shekhar A, Min M, Nawathey N, Bachir M, Brahmbhatt H. Wagh H, et al. Cureus. 2022 Jul 6;14(7):e26600. doi: 10.7759/cureus.26600. eCollection 2022 Jul. Cureus. 2022. PMID: 35936184 Free PMC article. Review.
The most common regimen is cyclophosphamide (Cy) with busulfan (Bu), followed by Cy with Bu and thiotepa (Thio). This meta-analysis aimed to evaluate the efficacy of different treatments by comparing mortality and morbidity causes and rates across groups. The mea …
The most common regimen is cyclophosphamide (Cy) with busulfan (Bu), followed by Cy with Bu and thiotepa (Thio). This meta-ana …
2,562 results